NanoString Blog
Category: Digital Spatial Profiling
Digital Spatial Profiling GeoMx DSP Spatial Biology Spatial Transcriptomics
GeoMx® DSP: What Surprised This Early Adopter Most
During her post doc years, Trieu My Van explored the effects of immuno check point blockade in melanoma patients, comparing samples from metastatic uveal and cutaneous melanoma tissues at the…
Clinical Research Digital Spatial Profiling GeoMx DSP Spatial Biology Spatial Transcriptomics
How the Field of Immuno-Oncology is Changing Fast
Immuno-oncology, also known as cancer immunotherapy, is a treatment that harnesses the power of our immune system to fight cancer. The selective efficacy of immunotherapies continues to provide impetus for…
Digital Spatial Profiling Neuroscience Q&A
Q&A with Dr. Stefan Prokop – Alzheimer’s: From the Amyloid Hypothesis to the Cellular Phase and Beyond
Stefan Prokop, MD, is a Neuropathologist and Research Fellow at the University of Pennsylvania School of Medicine. His work is focused on Alzheimer’s Disease (AD) with a specific interest in…
Digital Spatial Profiling Q&A
Q&A with Dr. Nick Reder: New Frontiers in Pathology with Digital Spatial Profiling and Light Sheet Microscopy
Dr. Nick Reder, MD, MPH, currently works at the Department of Pathology at the University of Washington in Seattle. Part of his time is spent in collaboration with mechanical engineers…
Digital Spatial Profiling
Revolutionizing Tissue Analysis with Digital Spatial Profiling
Recently, one of the early adopters of the Digital Spatial Profiling (DSP) technology, Michael Davies, MD, PhD, the Deputy Chairman and Associate Professor in the Department of Melanoma Medical Oncology…
Digital Spatial Profiling
Breaking Boundaries with NanoString’s Digital Spatial Profiling
Recently we had a conversation with key members of the scientific leadership team at NanoString. Joe Beechem, the Senior VP of Research & Development, and Alessandra Cesano, Chief Medical Officer,…
Digital Spatial Profiling Q&A
Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies
Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The…